Urinary Incontinence

Pay attention to when the leak happens. Leaking with cough, sneeze, laugh or lifting is stress incontinence, a support problem at the urethra. A sudden desperate urge followed by a leak before you reach the bathroom is urge incontinence, a bladder signaling problem. Many women have both, which is mixed incontinence, and the treatments differ, which is why the distinction matters more than the embarrassment. Your own description usually makes the diagnosis before any test does. The workup mostly confirms it and rules out imitators.

Less than most women fear. A careful history does most of the work, along with a urinalysis to rule out infection, a check that the bladder empties, and an exam that looks at tissue quality and pelvic support. After menopause, thinning tissue from estrogen loss is part of the picture surprisingly often, and treating it changes everything downstream. Invasive testing has its place, mostly before surgery. I personally like cystoscopy, but it is usually reserved for when conservative measures are not working.

Effective, for the right problem, and it is real rehabilitation with a trained therapist, not a pamphlet about Kegels. For stress incontinence it reduces or resolves leaking in a large share of women who stick with it, and it helps urge symptoms too. The catch is the same as any training program: it works if you do it, and it takes weeks to months. It is the right first move for most women, and losing nothing if you later choose a procedure.

It is the most studied incontinence operation in existence, with cure or major improvement in most women and durability measured in decades. The procedure is outpatient, takes well under an hour, and has a long track record. Risks are real but uncommon: temporary difficulty emptying, urge symptoms, and rare mesh complications. For a woman whose leaking has failed conservative treatment, it remains the standard her other options are measured against, and it is a very high bar.

Bulking trades some durability for simplicity. An injection at the urethra, done in minutes without incisions, adds closure where support has weakened. Newer materials such as Bulkamid hold up considerably better than the old ones did and can be repeated. Success rates run below a sling and touch-ups are expected, which is the honest trade: less procedure, less downside, less permanence. For women who want to avoid mesh, cannot tolerate a more invasive procedure, or want to start with the gentlest option, it has earned a real place.

No, and conflating them has scared women away from an operation with a strong record. The FDA action targeted large sheets of transvaginal mesh used for prolapse repair, which were pulled from that use. A midurethral sling is a narrow ribbon in a different location doing a different job, and it was specifically not part of the ban. Its complication rate is low and well documented across millions of procedures. Reasonable women can still prefer a non-mesh option, and bulking exists for exactly that preference. But the distinction is real and worth knowing.